Prestige Wealth Management Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-58
| Closed | -$11K | – | 1076 |
|
|
2021
Q2 | $11K | Buy |
58
+8
| +16% | +$1.52K | ﹤0.01% | 474 |
|
|
2021
Q1 | $8K | Sell |
50
-35
| -41% | -$5.6K | ﹤0.01% | 537 |
|
|
2020
Q4 | $13K | Buy |
85
+73
| +608% | +$11.2K | ﹤0.01% | 417 |
|
|
2020
Q3 | $1K | Hold |
12
| – | – | ﹤0.01% | 865 |
|
|
2020
Q2 | $1K | Sell |
12
-16
| -57% | -$1.33K | ﹤0.01% | 871 |
|
|
2020
Q1 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 607 |
|
|
2019
Q1 | – | Sell |
-105
| Closed | -$10K | – | 1236 |
|
|
2018
Q4 | $10K | Buy |
+105
| New | +$10K | 0.01% | 444 |
|